Public Health Impact After the Introduction of PsA-TT: The First 4 Years | Zendy

Fabien Diomandé | Zendy; Mamoudou Harouna Djingarey | Zendy; Doumagoum Moto Daugla | Zendy; Ryan T. Novak | Zendy; Paul A. Kristiansen | Zendy; JeanMarc Collard | Zendy; Kadidja Gamougam | Zendy; Denis Kandolo | Zendy; N Mbakuliyemo | Zendy; Leonard W. Mayer | Zendy; James Stuart | Zendy; Thomas A. Clark | Zendy; Carol TéviBénissan | Zendy; William Perea | Zendy; MariePierre Préziosi | Zendy; F. Marc LaForce | Zendy; Dominique A. Caugant | Zendy; Nancy Messonnier | Zendy; O Walker | Zendy; Brian Greenwood | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Public Health Impact After the Introduction of PsA-TT: The First 4 Years

Author(s) -

Fabien Diomandé,

Mamoudou Harouna Djingarey,

Doumagoum Moto Daugla,

Ryan T. Novak,

Paul A. Kristiansen,

JeanMarc Collard,

Kadidja Gamougam,

Denis Kandolo,

N Mbakuliyemo,

Leonard W. Mayer,

James Stuart,

Thomas A. Clark,

Carol TéviBénissan,

William Perea,

MariePierre Préziosi,

F. Marc LaForce,

Dominique A. Caugant,

Nancy Messonnier,

O Walker,

Brian Greenwood

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ499

Subject(s) - medicine , carriage , vaccination , incidence (geometry) , meningococcal disease , herd immunity , meningococcal vaccine , public health , meningitis , disease burden , environmental health , pediatrics , family medicine , immunology , neisseria meningitidis , immunization , population , nursing , antigen , biology , bacteria , genetics , physics , pathology , optics

During the first introduction of a group A meningococcal vaccine (PsA-TT) in 2010-2011 and its rollout from 2011 to 2013, >150 million eligible people, representing 12 hyperendemic meningitis countries, have been vaccinated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research